120 related articles for article (PubMed ID: 9174832)
1. Carboplatin plus etoposide regimen in advanced breast cancer. A phase II study.
Deltetto F; Durando A; Camanni M; Pesola D; Sberveglieri M; Arese P; Massobrio M
Eur J Gynaecol Oncol; 1997; 18(3):185-7. PubMed ID: 9174832
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of carboplatin and etoposide in metastatic breast cancer.
Crown J; Hakes T; Reichman B; Lebwohl D; Gilewski T; Surbone A; Currie V; Yao TJ; Hudis C; Seidman A
Cancer; 1993 Feb; 71(4):1254-7. PubMed ID: 8435802
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer.
van der Gaast A; Bontenbal M; Planting AS; Kok TC; Splinter TA
Ann Oncol; 1994 Nov; 5(9):858-60. PubMed ID: 7661927
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
[TBL] [Abstract][Full Text] [Related]
6. Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.
Fields KK; Elfenbein GJ; Perkins JB; Hiemenz JW; Janssen WE; Zorsky PE; Ballester OF; Kronish LE; Foody MC
Semin Oncol; 1993 Oct; 20(5 Suppl 6):59-66. PubMed ID: 8211217
[TBL] [Abstract][Full Text] [Related]
7. High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer.
deMagalhaes-Silverman M; Rybka WB; Lembersky B; Bloom EJ; Lister J; Pincus SM; Voloshin M; Wilson J; Ball ED
Am J Clin Oncol; 1996 Apr; 19(2):169-73. PubMed ID: 8610643
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival and engraftment.
Klumpp TR; Goldberg SL; Magdalinski AJ; Mangan KF
Bone Marrow Transplant; 1997 Aug; 20(4):273-81. PubMed ID: 9285541
[TBL] [Abstract][Full Text] [Related]
9. Platinum compounds in the treatment of advanced breast cancer.
Martín M
Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
Hainsworth JD; Gray JR; Stroup SL; Kalman LA; Patten JE; Hopkins LG; Thomas M; Greco FA
J Clin Oncol; 1997 Dec; 15(12):3464-70. PubMed ID: 9396399
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB
Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537
[TBL] [Abstract][Full Text] [Related]
13. Phase II evaluation of carboplatin and VP-16 for patients with metastatic breast cancer and only one prior chemotherapy regimen.
Barker LJ; Jones SE; Savin MA; Mennel RG
Cancer; 1993 Aug; 72(3):771-3. PubMed ID: 8334629
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer.
Greco FA; Hainsworth JD
Semin Oncol; 1996 Dec; 23(6 Suppl 16):7-10. PubMed ID: 9007113
[TBL] [Abstract][Full Text] [Related]
15. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of carboplatin and etoposide activity in pretreated breast cancer patients.
Viñolas N; Daniels M; Estapé J; Grau JJ; Palombo H; Solá C
Am J Clin Oncol; 1992 Apr; 15(2):160-2. PubMed ID: 1553906
[TBL] [Abstract][Full Text] [Related]
17. Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patients.
Gori S; Mosconi AM; Tabilio A; Falzetti F; Aristei C; Basurto C; Cherubini R; Latini P; Martelli MF; Tonato M; Colozza M
Tumori; 2001; 87(3):138-41. PubMed ID: 11504367
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).
Johnson DH; Paul DM; Hande KR; DeVore R
Semin Oncol; 1996 Dec; 23(6 Suppl 16):42-6. PubMed ID: 9007120
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin calculated with Chatelut's formula plus etoposide for elderly patients with small-cell lung cancer.
Matsui K; Masuda N; Yana T; Takada Y; Kobayashi M; Nitta T; Hirashima T; Fukuoka M
Intern Med; 2001 Jul; 40(7):603-6. PubMed ID: 11506300
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of etoposide, doxorubicin, and carboplatin in the treatment of advanced gastric cancer.
Wang X; Pang L; Feng J
Am J Clin Oncol; 2002 Feb; 25(1):71-5. PubMed ID: 11823701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
